LivaNova (LIVN) EBIT Margin Growth (1y) (2015 - 2026)
LivaNova (LIVN) EBIT Margin Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.32 Bn | 174.03 Bn | 6.27 Bn | -430.00 |
| 2 | Stryker | 128.59 Bn | 125.71 Bn | 3.81 Bn | 128.00 |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 301.00 |
| 4 | Boston Scientific | 67.77 Bn | 66.32 Bn | 3.61 Bn | 141.00 |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.46 Bn | 1.29 Bn | 102.00 |
| 6 | GE HealthCare Technologies | 28.44 Bn | 26.15 Bn | 1.98 Bn | -313.00 |
| 7 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn | 851.00 |
| 8 | Smith & Nephew | 26.77 Bn | 26.20 Bn | - | - |
| 9 | Koninklijke Philips | 25.24 Bn | 22.11 Bn | 2.07 Bn | 241.00 |
| 10 | LivaNova | 4.35 Bn | 3.81 Bn | 243.75 Mn | -390.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -390.00 |
| Dec 31, 2025 | 29.00 |
| Sep 30, 2025 | 390.00 |
| Jun 30, 2025 | 276.00 |
| Mar 31, 2025 | 983.00 |
| Dec 31, 2024 | 3,988.00 |
| Sep 30, 2024 | 964.00 |
| Jun 30, 2024 | 670.00 |
| Mar 31, 2024 | 640.00 |
| Dec 31, 2023 | -3,345.00 |
| Sep 30, 2023 | 5,380.00 |
| Jun 30, 2023 | -658.00 |
| Mar 31, 2023 | -485.00 |
| Dec 31, 2022 | -409.00 |
| Sep 30, 2022 | -5,873.00 |
| Jun 30, 2022 | 2,621.00 |
| Mar 31, 2022 | 626.00 |
| Dec 31, 2021 | 10,155.00 |
| Sep 30, 2021 | 963.00 |
| Jun 30, 2021 | -452.00 |